Navigation Links
Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation

CAMBRIDGE, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the Thomas Weisel Partners 2007 Healthcare Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website,

(Logo: )

The presentation will review recent events, clinical pipeline updates, and upcoming milestones. The presentation will be delivered at 8:35 a.m. ET on Friday, September 7, 2007 from the Four Seasons Hotel in Boston, MA. The presentation will be archived for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is

Editors' Note: This press release is also available under the Media section of the Company's website at:


Kyle Kuvalanka

(617) 761-4734

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. OpGen adds Thomas Pyle and James Ogle to board of directors
2. Jellyfish partners for sales tracking technology
3. GE Healthcare partners with UNC on breast cancer imaging research
4. Manufacturing partnership will move into biotech and biomedical spaces
5. Fergus joins Baird Venture Partners, Caden Bio
6. Avolte Venture Partners reaches capital goal
7. NimbleGen partners with UK biotech firm
8. Big pharma seeks Wisconsin biotech partnerships
9. Thompson in partnership to build ethanol plant
10. Johnson Controls partners on car satellite linkup
11. Doyle, WARF announce partnership to lure stem cell companies
Post Your Comments:
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: ) ... provide their customers enhanced security to access and ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):